Ensign Peak Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-98,112
| Closed | -$368K | – | 1732 |
|
|
2024
Q1 | $368K | Buy |
98,112
+4,662
| +5% | +$17.5K | ﹤0.01% | 1673 |
|
|
2023
Q4 | $917K | Buy |
93,450
+12,100
| +15% | +$119K | ﹤0.01% | 1435 |
|
|
2023
Q3 | $679K | Hold |
81,350
| – | – | ﹤0.01% | 1458 |
|
|
2023
Q2 | $1.08M | Hold |
81,350
| – | – | ﹤0.01% | 1188 |
|
|
2023
Q1 | $942K | Hold |
81,350
| – | – | ﹤0.01% | 1287 |
|
|
2022
Q4 | $665K | Buy |
81,350
+36,200
| +80% | +$296K | ﹤0.01% | 1494 |
|
|
2022
Q3 | $262K | Hold |
45,150
| – | – | ﹤0.01% | 1769 |
|
|
2022
Q2 | $200K | Hold |
45,150
| – | – | ﹤0.01% | 1790 |
|
|
2022
Q1 | $411K | Hold |
45,150
| – | – | ﹤0.01% | 1635 |
|
|
2021
Q4 | $924K | Buy |
+45,150
| New | +$924K | ﹤0.01% | 1338 |
|